🧬 #PNPLA3 is a major genetic driver of #MASLD severity
🔸Linked to higher ALT/AST & liver stiffness
🔸Homozygous carriers had 2.57× higher risk of stiffness ≥9.1 kPa
🔸HSD17B13 lowered liver injury markers but not fibrosis risk
📖 #OpenAccess 👉 bit.ly/48sszie
🔸Linked to higher ALT/AST & liver stiffness
🔸Homozygous carriers had 2.57× higher risk of stiffness ≥9.1 kPa
🔸HSD17B13 lowered liver injury markers but not fibrosis risk
📖 #OpenAccess 👉 bit.ly/48sszie